Cargando…
BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
Despite recent advances in the management of BRCA1 mutated high-grade serous ovarian cancer (HGSC), the physiology of these tumors remains poorly understood. Here we provide a comprehensive molecular understanding of the signaling processes that drive HGSC pathogenesis with the addition of valuable...
Autores principales: | Bradbury, Melissa, Borràs, Eva, Castellví, Josep, Méndez, Olga, Sánchez-Iglesias, José Luis, Pérez-Benavente, Assumpció, Gil-Moreno, Antonio, Sabidó, Eduard, Santamaria, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924168/ https://www.ncbi.nlm.nih.gov/pubmed/35292711 http://dx.doi.org/10.1038/s41598-022-08461-0 |
Ejemplares similares
-
Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
por: Bradbury, Melissa, et al.
Publicado: (2021) -
A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management
por: Bradbury, Melissa, et al.
Publicado: (2022) -
Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019) -
Ovarian Fibrosarcoma: Clinicopathologic Considerations about the Intraoperative and Post-Surgical Procedures
por: García Jiménez, Angel, et al.
Publicado: (2009) -
Potent immunogenicity in BRCA1‐mutated patients with high‐grade serous ovarian carcinoma
por: Dai, Ying, et al.
Publicado: (2018)